Mineralys reports Phase 2 trial success for lorundrostat, showing BP and kidney improvements in CKD patients with favorable ...

Browns Mills, N.J.-based Deborah Heart and Lung Center named Geurys Rojas-Marte, MD, medical director of advanced heart failure and pulmonary hypertension programs, the hospital said in a June 14 ...

The latest clinical win follows a dual set of phase 3 and phase 2 results back in March. In that data drop, Mineralys reported that lorundrostat reduced systolic blood pressure in a late-stage study ...

Shares of Mineralys Therapeutics Inc. (NASDAQ:MLYS) jumped 7.9% following the release of promising topline data from the ...

Investing.com -- Mineralys Therapeutics Inc (NASDAQ: MLYS) stock surged 7.9% after reporting positive topline data from its Phase 2 Explore-CKD trial for lorundrostat in patients with hypertension and ...

The retina has always served as an invaluable, non-invasive portal to the vascular system, with retinal microvascular changes ...

The DASH (Dietary Approaches to Stop Hypertension) diet effectively treated high blood pressure among type 2 diabetics, ...

The researchers hypothesized that sildenafil would increase oxygen flow to the placenta and to the unborn fetus, reducing ...

For patients undergoing noncardiac surgery, neurocognitive outcomes do not differ with hypotension-avoidance and hypertension-avoidance strategies.

Diagnosis of primary open-angle glaucoma (POAG) is associated with a reduction in mental health scores, according to a study.

Concurrent hypertension and type 2 diabetes elevated mortality risks more than either condition alone among adults in the US.

A concerning trend has emerged in cardiovascular health awareness among American adults, according to new research published in JAMA Cardiology. The study reveals that hypertension awareness has ...